Newest Pharmacology Findings in Cardiovascular Diseases
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: closed (31 January 2025) | Viewed by 1173
Special Issue Editor
Interests: pharmacology; clinical pharmacology; cardiovascular; neuronal system; orthopaedic
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cardiovascular diseases (CVDs) remain a leading cause of death globally, necessitating continuous innovation in treatment and prevention. This special issue focuses on the emerging trends transforming cardiovascular pharmacology, highlighting the latest research and breakthroughs. We invite submissions exploring novel drug targets and mechanisms, such as inflammation and RNA therapeutics.
Additionally, we seek contributions to individual medicine advancements like genetic profiling and biomarker-guided therapy. Manuscripts are encouraged to discuss drug repurposing, combination therapies, and technological innovations like wearable devices and AI in drug discovery. Finally, we welcome research on public health initiatives and lifestyle interventions for CVD prevention. This issue aims to advance the field and improve patient outcomes by showcasing these cutting-edge developments.
Dr. Andrea Gažová
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular pharmacology
- drug targets
- inflammation
- RNA therapeutics
- precision medicine
- genetic profiling
- biomarkers
- drug repurposing
- wearable devices
- artificial intelligence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
